Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4 USD | +3.63% | +9.59% | -27.27% |
May. 15 | Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M | MT |
May. 15 | Marker Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 35.68M |
---|---|---|---|---|---|
Net income 2024 * | -17M | Net income 2025 * | -31M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.13
x | P/E ratio 2025 * |
-3.13
x | Employees | 8 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.8% |
Latest transcript on Marker Therapeutics, Inc.
1 day | +3.63% | ||
1 week | +9.59% | ||
Current month | +3.36% | ||
1 month | -3.15% | ||
3 months | -5.21% | ||
6 months | -5.66% | ||
Current year | -27.27% |
Managers | Title | Age | Since |
---|---|---|---|
Juan Vera
CEO | Chief Executive Officer | 44 | 18-10-16 |
Monic Stuart
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Garrett
CTO | Chief Tech/Sci/R&D Officer | 59 | 19-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Norman Eansor
CHM | Chairman | 63 | 18-10-16 |
Steven Elms
BRD | Director/Board Member | 60 | 19-08-05 |
Katharine Knobil
BRD | Director/Board Member | 60 | 21-12-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-12 | 4 | +3.63% | 25,476 |
24-06-11 | 3.86 | +11.24% | 71,928 |
24-06-10 | 3.47 | 0.00% | 47,053 |
24-06-07 | 3.47 | +4.20% | 10,312 |
24-06-06 | 3.33 | -8.77% | 13,420 |
Delayed Quote Nasdaq, June 12, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.27% | 34.43M | |
+48.54% | 56.87B | |
+37.15% | 39.72B | |
-6.02% | 39.27B | |
-6.90% | 28.73B | |
+12.97% | 26.21B | |
-16.91% | 19.79B | |
+31.71% | 12.28B | |
+28.18% | 12.23B | |
+0.38% | 12.12B |
- Stock Market
- Equities
- MRKR Stock